AI’s Role in Global Health Policy Explored in New Research

By Sumona Bose

January 9, 2024

Introduction

Artificial intelligence (AI) has the potential to transform global health policy, according to a recent study published in the Journal of Health Policy and Planning. The research highlights the various ways in which AI can contribute to inclusive healthcare practices and ethical access, while also identifying areas for improvement. The study emphasizes that AI has primarily been used in delivering public services rather than policymaking. However, the researchers argue that AI can play a crucial role in shaping global health policy by providing valuable insights and analysis. By harnessing the power of big data and AI, policymakers can assess the potential outcomes of their interventions and make more informed decisions.

AI’s Potential in Global Health

One of the key benefits of AI in health policy is its ability to analyze heterogeneous data from various sources, including healthcare devices, clinical records, and environmental data. This comprehensive analysis can help policymakers understand the complex factors that influence public health, such as access to healthcare, socioeconomic conditions, and information systems.The researchers also highlight the importance of considering multiple dimensions when developing policy options. They suggest that future studies should provide policymakers with real-time learning opportunities, address pandemics, and prevent non-communicable diseases. By tracking key performance indicators like mortality, morbidity, and life expectancy, policymakers can make evidence-based decisions that improve overall health outcomes.

Figure 1: A Framework for Interactions between AI and the elements of health policy triangle.

AI’s Contribution to Global Health Policy

Furthermore, the study emphasizes the need for transparency and accountability in policymaking. AI can help policymakers consider factors like public preferences, societal voices, and institutional transparency when developing policies. This ensures that policies are aligned with the needs and values of the population, ultimately improving life expectancy, quality of life, and social well-being.The researchers also highlight specific areas where AI can enhance global health policy. For example, AI can improve situational awareness by identifying the causes of policy failure and providing early crisis warnings. It can also reduce decision-making bias by exploring the social context and improving communication effectiveness. Additionally, AI applications like geographic information systems (GIS) can integrate and analyze geospatial data, enabling better disease surveillance and prevention.

Figure 2: A Framework for AI-equipped policymaking: existing knowledge and future directions

Conclusion

The study concludes by emphasizing that AI has the potential to reconfigure the policy process by enabling new methods of data collection, analysis, and decision-making. By equipping health systems with AI capabilities, policymakers can make more informed decisions and achieve progressive goals.Overall, this research highlights the significant role that AI can play in shaping global health policy. By leveraging AI’s capabilities, policymakers can improve healthcare access, address inequalities, and make evidence-based decisions that benefit global healthcare.

Reference url

Recent Posts

Donanemab Alzheimer’s Approval: A New Era in Treatment

By João L. Carapinha

August 8, 2025

The EMA granted marketing authorization for donanemab, a monoclonal antibody targeting beta-amyloid plaques. It treats early symptomatic Alzheimer's disease (mild cognitive impairment or mild dementia with confirmed amyloid pathology). This approval highlights donanemab's role in Alzheimer's trea...
Building a Better Ecosystem for Digitally Enabled Diabetes Care in Europe
Digitally enabled diabetes care is rapidly transforming the management of Type 2 diabetes (T2D) across Europe. How does expanding access to these digital solutions improve health outcomes and reduce costs for individuals and health systems? Early evidence and recent policy recommendations (publis...
AI in Real-World Evidence: Insights from Mitch Higashi

By Staff Writer

August 7, 2025

In this update, we review the Q&A with Mitch Higashi, PhD, ISPOR’s Associate Chief Science Officer published on Pharmalive. It discusses AI in Real-World Evidence (RWE) and health technology assessments (HTA). Key themes include AI-driven early disease detection and NLP tackling unstructured ...